Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/17 → 3/31/19 |
Funding
- National Institutes of Health: $108,576.00
Abuse liability and anti-addiction potential of the atypical mu opioid receptor agonist IBNtxA
- Keck, Thomas (PI)
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/17 → 3/31/19 |